Thursday, September 7
(agenda subject to change)
3:00 PM Registration
4:00 - 4:30 Welcome and Overview of Program
Kenneth Sherman, MD, PhD - University of Cincinnati
Session 1 Epidemiology and Scope of Disease
Moderator: Kenneth Sherman, MD, PhD - University of Cincinnati
4:30 – 5:10 Epidemics/Pandemics/Outbreaks: What Keeps Me Up at Night
John T. Brooks, MD - U.S. Centers for Disease Control and Prevention
5:10 – 5:45 HIV Treatment Regimens Affecting the Liver
Kristen Marks, MD - Weill Cornell Medicine
5:45 – 6:30 NASH/HCC and Viral Hepatitis in PLWH: Epidemiologic Trends
Richard Sterling, MD - Virginia Commonwealth University
6:30 – 6:45 Selected Abstract
Microbial Translocation is Associated with Hepatic Fibrosis but not Steatosis in Women with and without HIV
Maria Duarte, MD - University of California, San Francisco
6:45 - 7:00 Panel Discussion
John T. Brooks, MD, Kristen Marks, MD, Richard Sterling, MD
7:00 – 9:00 Poster Reception (all poster presenters at posters)
Friday, September 8
(agenda subject to change)
7:30 - 8:00 AM Continental Breakfast
Session 2 Fatty Liver Disease in PLWH
Moderator: David Thomas, MD, MPH - Johns Hopkins University School of Medicine
8:00 - 8:30 Mechanisms of Liver Injury Relevant to the Patient with HIV
Raymond T. Chung, MD - Harvard Medical School
8:30 – 9:00 Fatty Liver Disease in HIV: It's Just NAFLD/NASH: Pro
Phyllis Tien, MD - University of California, San Francisco
9:00 – 9:30 Fatty Liver Disease in HIV: It's Not Simple NAFLD/NASH
Jennifer Price, MD - University of California, San Francisco
9:30 - 9:45 Selected Abstract
Single-Cell Atlas of the Liver Myeloid Compartment with Cure of Chronic Viral Hepatitis
Nadia Alatrakchi, MD, PhD - Massachusetts General Hospital
9:45 - 10:00 Selected Abstract
The Association of Lipidomic Profiles with Hepatic Steatosis and Visceral Fat Volume in Persons With HIV
Curtis Gabriel, MD, PhD - Vanderbilt University Medical Center
10:00 - 10:45 Break
Session 3 Hepatitis B and HIV
Moderator: Kenneth E. Sherman, MD, PhD - University of Cincinnati
10:45 – 11:45 Immune and Non-Immune Targets of HBV Cure: Does Single or Combination Therapy Make Sense
Shyamasundaran Kottilil, MD, PhD - University of Maryland, School of Medicine
11:45 – 12:20 HDV: New Treatments
Kenneth E. Sherman, MD, PhD - University of Cincinnati
12:20 – 12:35 Selected Abstract
Prevalence of Hepatitis E Infection in HIV-Negative and HIV-Positive Transplant Recipients
Debra Yen, MD - University of Cincinnati
12:35 – 1:00 Panel Discussion
Shyamasundaran Kottilil, MD, PhD and Kenneth E. Sherman, MD, PhD
1:05 – 2:00 Small Group Case-based Lunches with Experts (Groups of 10 or less meet in private dining)
Arthur Kim, MD, David Thomas, MD, MPH, Glenn Treisman, MD, PhD
Saturday, September 9
(agenda subject to change)
7:30 - 8:00 AM Continental Breakfast
Session 4 Other Viral Hepatitis
Moderator: Kenneth E. Sherman, MD, PhD - University of Cincinnati
8:00 - 8:30 Can HCV and HCV/HIV Actually be Eliminated? Reality vs. the Dream
David Thomas, MD, MPH - Johns Hopkins University School of Medicine
8:30 - 9:00 Hepatitis Vaccine Responses in HIV
Kristen Marks, MD - Weill Cornell Medicine
9:00 - 9:15 Selected Abstract
Factors Contributing to Non-Treatment Among Patients with Hepatitis C Virus Mono-infection and HIV Coinfection: A Retrospective Cohort Study
Ivan Berezowski, MD - The George Washington University Hospital
9:15 - 9:30 Panel Discussion
David Thomas, MD, MPH and Kristen Marks, MD
9:30 - 9:45 Break
Session 5 Drugs & Behavioral Issues and Therapies
Moderator: Phyllis Tien, MD - University of California, San Francisco
9:45 - 10:15 Treatments for NAFLD/NASH in PLWH
Jennifer Price, MD - University of California, San Francisco
10:15 - 10:30 Selected Abstract
Body Composition and Cognitive Impairment in People Living with HIV in the Miami Adult Studies on HIV Cohort
Haley R. Martin, MS, RDN, LDN - Florida International University
10:30 - 11:15 HCV Treatment Outcomes on Extrahepatic Manifestations
Arthur Kim, MD - Massachusetts General Hospital
11:15 - 12:15 Behavioral Modification in PLWH: Alcohol, Diet and Drugs
Glenn Treisman, MD, PhD - Johns Hopkins Medicine
12:15 - 12:30 Panel Discussion
Jennifer Price, MD, Arthur Kim, MD, Glenn Treisman, MD, PhD
Session 6 Research Agenda - Plans for the Next Two Years
Moderator: Kenneth E. Sherman, MD, PhD - University of Cincinnati
12:30 - 1:00 NIH Goals and Opportunities
Roger Ptak - NIH / NIAID / DAIDS / TRP / DDPRB
1:00 - 1:20 Summary of Key Research Agenda Items
Kenneth E. Sherman, MD, PhD - University of Cincinnati
1:20 - 1:45 Conference Wrap-Up & To-go Lunches
Kenneth E. Sherman, MD, PhD - University of Cincinnati
2:30 Optional Group Hike
7:00 Group Dinner
